Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Lester J. Peters, Danny Rischin, Brian O’Sullivan et al.|Journal of Clinical Oncology|2010Cited by 806
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised studyJean-François Bosset, Laurence Collette, G. Calais et al.|The Lancet Oncology|2014Cited by 727
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology GroupDanny Rischin, Liz Kenny, Lester J. Peters et al.|Journal of Clinical Oncology|2010Cited by 372
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid Thomson, Sue S. Yom, Jimmy J. Caudell et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 211